Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid Gel for Burning Mouth Syndrome
NCT05729529Unknown
- Sponsor
- University of Catania
- Start
- Jan 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of alpha-lipoic acid in burning mouth syndrome (BMS), sponsored by University of Catania. Primary endpoint: Evolution of burning mouth at 6 months. Status: unknown.
02
Drugs
alpha-lipoic acid
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT05729529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05729529.